Massachusetts Financial Services’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Other funds holding ACAD
Massachusetts Financial Services's ACAD Position: Q3 2026 in Review
Massachusetts Financial Services reduced its Acadia Pharmaceuticals (ACAD) stake by 31% in Q3 2026, selling an estimated $7.2M and leaving 587,084 shares worth $11.8M. The position accounts for ﹤0.01% of the portfolio, ranked #725.
Massachusetts Financial Services first reported a position in ACAD in Q1 2016 and has held it in 21 quarters since. The position peaked at $28.6M in Q4 2025. 304 funds tracked by Wall St. Rank hold ACAD as of Q3 2026.
- Massachusetts Financial Services held 587,084 shares of Acadia Pharmaceuticals worth $11.8M as of Q3 2026.
- Massachusetts Financial Services sold 268,351 Acadia Pharmaceuticals shares in Q3 2026, an estimated $7.2M.
- Acadia Pharmaceuticals made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q3 2026, its #725 holding.
- Massachusetts Financial Services first reported a position in Acadia Pharmaceuticals in Q1 2016 and has held it in 21 quarters since.
- Massachusetts Financial Services's Acadia Pharmaceuticals position peaked at $28.6M in Q4 2025.
- 304 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2026.
Based on Massachusetts Financial Services's 13F filing for Q3 2026, filed 12 Nov 2026.